The groundbreaking discovery that free fatty acid receptor 4 (Ffar4) plays a piv...
A new study published in *Nature Communications* sheds light on the physiologica...
The landscape of maternal and infant healthcare in the United States is marred b...
In recent groundbreaking research, scientists at the Monell Chemical Senses Cent...
The intricate three-dimensional shapes of proteins are proving to be invaluable ...
Blueprint Medicines has announced the termination of its clinical-stage CDK2 inh...
Gilead Sciences is further extending its reach beyond its roots in infectious di...
Johnson & Johnson has achieved a breakthrough in the treatment of non-small cell...
According to a statement released by Merck, its human papillomavirus vaccination...
Investors are clearly in no doubt over the functionality of Tune Therapeutics’ e...
CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 20...
The proposed deal comes soon after Sage implemented a restructuring plan to focu...
Gilead and LEO Pharma have entered into a strategic collaboration to expedite th...
NVIDIA starts 2025 by announcing a trio of partnerships and a research collabora...
Nano milling is a vital technique for developing fine particle-sized drug formul...
